Research and Development

A powerful engine for discovery and development of cancer medicines with breakthrough potential.

Our pipeline

Advancing clinical research programs in a number of important unmet medical needs.

MORE

Iclusig (ponatinib)

Our science

A unique, highly targeted approach to cancer drug discovery and development.

MORE

Brigatinib (AP26113)

An investigational ALK inhibitor in non-small cell lung cancer.

MORE